| 1. |
|
|
| 2. |
|
|
| 3. |
- Bergkvist, Karin, et al.
(författare)
-
Hospital care or home care after allogeneic hematopoietic stem cell transplantation : patients' experiences of care and support
- 2013
-
Ingår i: European Journal of Oncology Nursing. - : Elsevier BV. - 1462-3889 .- 1532-2122. ; 48, s. S468-S468
-
Tidskriftsartikel (refereegranskat)abstract
- PURPOSE:Treatment at home during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation (HSCT) has been an option for patients at our center since 1998. Earlier studies have shown that home care is safe and has medical advantages. In this study, we present patients' experiences of care and support while being treated in hospital or at home during the acute post-transplantation phase.METHOD:Patients (n = 41, 22 in hospital care and 19 in home care) answered the SAUC questionnaire at discharge (when home, or from hospital). Both statistical analysis and deductive content analysis were used.RESULTS:The patients were highly satisfied with the care and support during the acute post-transplantation phase. Patients in home care were found to be more satisfied with care in general than patients in hospital care. The importance of safety, empathy, and encouragement from healthcare staff were expressed regardless of where care was given. Patients also felt that receipt of continuous, updated information during treatment was important and they had a strong belief in HSCT but were uncertain of the future regarding recovery.CONCLUSIONS:The main findings of this study were that in comparison to hospital care, home care does not appear to have a significant negative effect on patients' experiences of care and support during the acute post-transplantation phase. In addition patients in home care felt safe, seen as a person and encouragement seem to empower the patients at home. Thus, this study may encourage other transplantation centers to provide home care if the patients want it.
|
|
| 4. |
- Svanberg, Anncarin, 1956-, et al.
(författare)
-
Oral cryotherapy to prevent total parenteral nutrition for patients undergoing bone marrow transplantation
- 2006
-
Ingår i: Bone Marrow Transplantation. - 0268-3369 .- 1476-5365. ; 37, s. s271-s271
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction: Mucositis is a major complication in intensive chemotherapy, which often necessitates total parenteral nutrition (TPN). While the side effects of the conditioning regimes vary with regard to degree of severity among individual’s and between transplant types, the gastrointestinal (GI) toxicities have an immense impact on the short-term nutritional status of the transplant patients. Additionally, patients who have undergone allogeneic transplant (related or unrelated) are uniquely susceptible to graft versus host disease (GvHD), which has both short and long-term nutritional consequences. TPN imply an increased risk for infections. There is a lack of knowledge concerning the effect of oral cryotherapy on nutrition for patients treated with superintensive chemotherapy before bone marrow transplantation.Objective: The objective with the present study was to evaluate if oral cryotherapy during chemotherapy may reduce number of days with TPN due to less intensity of oral pain from mucositis. Material and metod: All patients 18 years and older, who were scheduled for bone marrow transplantation were included consecutively and randomised to oral cryotherapy or routine oral care. A stratified randomisation was used with regard to type of transplantation. The number of days of total parenteral nutrition was collected from the patient’s medical and nursing record.Result: The result showed that fewer patients in the experimental group (41%) than in the control group (51%) received TPN (n = 16 vs 20). There was a tendency to fewer days with TPN in the experimental group (4.2 ± 3.9) compared to the control group (6.6 ± 4.8) among patients with autologous transplantation even though it did not reach a significant level. The kreatinin level was significantly lower in the experimental group at day 3-5, 9 and 9-21.Conclusion: Oral cryotherapy indicates that fewer patients are in the need of total parenteral nutrition (TPN) and that the number of days with TPN is reduced for patients treated with superintensive chemotherapy before autologous bone marrow transplantation.
|
|
